Community-EngagedResearch on COVID-19TestingAmongUnderservedand/orVulnerablePopulationsPhaseII
Project Number1U01MD017423-01
Former Number1U01MH129920-01
Contact PI/Project LeaderBAUM, MARIANNA K
Awardee OrganizationFLORIDA INTERNATIONAL UNIVERSITY
Description
Abstract Text
PROJECT SUMMARY
The COVID-19 pandemic has caused unprecedented public health and economic consequences globally and
in the United States. Long-standing social inequities have been magnified and vulnerable communities have
been disproportionately burdened by the pandemic. In Miami-Dade County, Florida, where minority populations
experience a high level of social vulnerability, Blacks and Hispanics are overrepresented in COVID-19 related
hospitalizations and deaths compared to national rates. Further, Miami-Dade County continues to experience
COVID-19 rates well above the state and national levels. Effective vaccines are now available, yet vaccination
rates have been persistently lower among U.S. minorities, broadening disparities in COVID-19 outcomes. As
such, expanded SARS-CoV-2 testing and vaccine acceptance is critical to mitigating community spread in
underserved and vulnerable communities. In this application for PhaseII of the RADx-UP project, we will apply
the knowledge gained during Phase I to expand community outreach to increase testing and vaccine uptake in
minority communities to decrease disparities that contribute to burden of COVID-19 in underserved and
vulnerablepopulations. We propose to continue our RADx-UP community-engagedresearch by employing
new recruitment strategies in conjunction with four community partners to increase reach of testing that include
engaging faith leaders and minority health care providers, and placing our mobile testing (and vaccination) unit
in church parking areas. We will also conduct a longitudinal study among participants who completed Phase I
of the study to assess (a) changes in infection and vaccination status, (b) how the availability of vaccines
affects attitudes, beliefs, and behaviors related to testing, (c) changes in SDoH and their impact on COVID-19testing and vaccine uptake/hesitancy, and (d) the relationship between mental resilience, mental health, and
testing and vaccine uptake/hesitancy, and (e) other RADx-UP common data elements. We will also conduct
post-infection and post-vaccination studies on antibody production and subsequent infections. For the
proposed PhaseII application, we have partnered with new community organizations, including Keeping the
Faith to Fight COVID-19, an organization of minority health care providers working with Black and Black
Hispanic churches, and with the Community Engagement Alliance (CEAL) Against COVID-19 Disparities
initiative. We are currently conducting RADx-UP Phase I with established infrastructure and community
partnerships to accomplish the aims and enable rapid and measurable impact in access and uptake of SARS-
CoV-2 testing by underserved and vulnerablepopulations. Our community partners have the resources to
provide community engagement, public health mitigation, and follow-up care for cases who test positive. Our
strategy includes Scientific and Community Advisory Boards; a mobile testing unit; a CLIA-licensed laboratory
headed by the PI of this application; data mining and longitudinal approaches for data analyses; and a
research team experienced in recruiting and retaining members of the communities targeted in this proposal.
Public Health Relevance Statement
NARRATIVE
The aim of this study is to conduct community-based, collaborative research to increase COVID-19testing and
vaccine uptake in hard-to-reach populations, understand the social determinants of health that contribute to
disparities in COVID-19testing and outcomes, and mobilize the community in order to develop strategies to
minimize the effects of the current epidemic. In Miami-Dade County, which continues to experience COVID-19
rates well above the state and national levels, socially vulnerable minority populations are at increased risk of
COVID-19 infection and poorer health outcomes. We will utilize an established infrastructure and community
partnerships to increase testing in the community with a mobile testing unit, and use culturally-appropriate
questionnaires to assist in understanding barriers and facilitators to increase uptake of testing and vaccines in
the underserved communities.
National Institute on Minority Health and Health Disparities
CFDA Code
310
DUNS Number
071298814
UEI
Q3KCVK5S9CP1
Project Start Date
01-January-2022
Project End Date
30-November-2023
Budget Start Date
01-January-2022
Budget End Date
30-November-2022
Project Funding Information for 2022
Total Funding
$1,105,562
Direct Costs
$749,534
Indirect Costs
$356,028
Year
Funding IC
FY Total Cost by IC
2022
NIH Office of the Director
$1,105,562
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1U01MD017423-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1U01MD017423-01
Patents
No Patents information available for 1U01MD017423-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1U01MD017423-01
Clinical Studies
No Clinical Studies information available for 1U01MD017423-01
News and More
Related News Releases
No news release information available for 1U01MD017423-01
History
No Historical information available for 1U01MD017423-01
Similar Projects
No Similar Projects information available for 1U01MD017423-01